Neuraxis, INC
Develops neuromodulation therapies for disorders of gut-brain interactions.
NRXS | US
Overview
Corporate Details
- ISIN(s):
- US64134X2018
- LEI:
- Country:
- United States of America
- Address:
- 11611 N. MERIDIAN ST, 46032 CARMEL
- Website:
- https://neuraxis.com/
- Sector:
- Manufacturing
Description
Neuraxis, Inc. is a medical technology company that develops and commercializes neuromodulation therapies for chronic and debilitating conditions, particularly disorders of gut-brain interactions (DGBIs). The company's core technology is Percutaneous Electrical Nerve Field Stimulation (PENFS). Its flagship product, IB-Stim, is an FDA-cleared, non-surgical, drug-free device for treating functional abdominal pain associated with Irritable Bowel Syndrome (IBS) and functional dyspepsia. While initially focused on the pediatric and adolescent population, Neuraxis is expanding its therapies to adult patients. The company's portfolio also includes RED, an FDA-cleared device for the testing and evaluation of patients with chronic constipation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Neuraxis, INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Neuraxis, INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Neuraxis, INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
